|
KPNA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.28879999794896E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.2285999995143E-07 |
| Normal-vs-Stage2 |
4.31389999999698E-05 |
| Normal-vs-Stage3 |
1.977410E-03 |
| Normal-vs-Stage4 |
3.522200E-02 |
| Stage1-vs-Stage2 |
8.441000E-01 |
| Stage1-vs-Stage3 |
7.569600E-01 |
| Stage1-vs-Stage4 |
8.828000E-01 |
| Stage2-vs-Stage3 |
6.880000E-01 |
| Stage2-vs-Stage4 |
9.954600E-01 |
| Stage3-vs-Stage4 |
7.735600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.23519999970657E-08 |
| Normal-vs-AfricanAmerican |
6.13280000005823E-07 |
| Normal-vs-Asian |
1.88524999999995E-05 |
| Caucasian-vs-AfricanAmerican |
9.739800E-01 |
| Caucasian-vs-Asian |
1.656210E-02 |
| AfricanAmerican-vs-Asian |
8.760300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.02510000277567E-09 |
| Normal-vs-Female |
1.655000E-03 |
| Male-vs-Female |
1.751760E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.73590000000146E-05 |
| Normal-vs-Extreme_Weight |
7.38679994949365E-09 |
| Normal-vs-Obese |
2.586000E-04 |
| Normal-vs-Extreme_Obese |
8.06490000000437E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.698200E-01 |
| Normal_Weight-vs-Obese |
3.532400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.920000E-01 |
| Extreme_Weight-vs-Obese |
3.784000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.807400E-01 |
| Obese-vs-Extreme_Obese |
2.658400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.152300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.77180000000044E-05 |
| Normal-vs-Age(61-80Yrs) |
1.2738999966011E-08 |
| Normal-vs-Age(81-100Yrs) |
7.70330000010588E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.895600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.963770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.153800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.630470E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.264000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.639600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.64850000503736E-08 |
| Normal-VS-Type2 PRCC |
6.16069999459512E-08 |
| Normal-VS-KIRP CIMP |
2.026000E-01 |
| Normal-VS-Unclassified PRCC |
6.843000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.467800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.350200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.544400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.727400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.718760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.551200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.2804982608734E-11 |
| Normal-vs-N1 |
1.898360E-02 |
| Normal-vs-N2 |
1.93761999999209E-05 |
| N0-vs-N1 |
4.750100E-02 |
| N0-vs-N2 |
1.212190E-01 |
| N1-vs-N2 |
3.230700E-04 |
|
|
